Proteomic assessment of a cell model of spinal muscular atrophy

BMC Neuroscience

Volumn 12, Issue , 2011, Pages

  Wu, Chia Yen ^a   Whye, Dosh ^b   Glazewski, Lisa ^c   Choe, Leila ^a   Kerr, Douglas ^d   Lee, Kelvin H ^a   Mason, Robert W ^a,c,e   Wang, Wenlan ^c,e  

^a UNIVERSITY OF DELAWARE   (United States)

^b NewYork Presbyterian Hospital   (United States)

^c NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^d BIOGEN   (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 8; NOGGIN; PROTEIN P21; RETINOIC ACID; SONIC HEDGEHOG PROTEIN; SURVIVAL MOTOR NEURON PROTEIN 1; ANTIBODY; FGF8 PROTEIN, MOUSE; FIBROBLAST GROWTH FACTOR; GREEN FLUORESCENT PROTEIN; NERVE PROTEIN; PROTEOME;

ANIMAL CELL; ARTICLE; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOSKELETON; EMBRYO; EMBRYONIC STEM CELL; ENERGY METABOLISM; GENE; GENE DELETION; MOUSE; NEUROFILAMENT; NEUROMUSCULAR DISEASE; NONHUMAN; PARALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; SMN1 GENE; SPINAL MUSCULAR ATROPHY; WESTERN BLOTTING; ANIMAL; ANIMAL EMBRYO; CELL DIFFERENTIATION; CELL LINE; DISEASE MODEL; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOTONEURON; PATHOLOGY; PHYSIOLOGY; SPINAL CORD; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; ANTIBODIES; CELL DIFFERENTIATION; CELL LINE, TRANSFORMED; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; FIBROBLAST GROWTH FACTOR 8; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; GREEN FLUORESCENT PROTEINS; MICE; MICE, TRANSGENIC; MOTOR NEURONS; MUSCULAR ATROPHY, SPINAL; NERVE TISSUE PROTEINS; PROTEOME; PROTEOMICS; SPINAL CORD; STEM CELLS; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 79952347922     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-12-25     Document Type: Article

References (75)

1. Pearn J. Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 1978, 15(6):409-413. 10.1136/jmg.15.6.409, 1013753, 745211.
2. Lunn MR, Wang CH. Spinal muscular atrophy. Lancet 2008, 371(9630):2120-2133. 10.1016/S0140-6736(08)60921-6, 18572081.
3. Crawford TO, Pardo CA. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996, 3(2):97-110. 10.1006/nbdi.1996.0010, 9173917.
4. Pearn J. Classification of spinal muscular atrophies. Lancet 1980, 1(8174):919-922. 10.1016/S0140-6736(80)90847-8, 6103267.
5. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80:155-165. 10.1016/0092-8674(95)90460-3, 7813012.
6. Lorson CL, Hahnen E, Androphy EJ, Wirth B. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci USA 1999, 96(11):6307-6311. 10.1073/pnas.96.11.6307, 26877, 10339583.
7. Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD. A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 1999, 8(7):1177-1183. 10.1093/hmg/8.7.1177, 10369862.
8. Paushkin S, Gubitz AK, Massenet S, Dreyfuss G. The SMN complex, an assemblyosome of ribonucleoproteins. Curr Opin Cell Biol 2002, 14(3):305-312. 10.1016/S0955-0674(02)00332-0, 12067652.
9. Pellizzoni L. Chaperoning ribonucleoprotein biogenesis in health and disease. EMBO Rep 2007, 8(4):340-345. 10.1038/sj.embor.7400941, 1852756, 17401408.
10. Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?. Nat Rev Neurosci 2009, 10(8):597-609. 10.1038/nrn2670, 2853768, 19584893.
11. Carissimi C, Saieva L, Baccon J, Chiarella P, Maiolica A, Sawyer A, Rappsilber J, Pellizzoni L. Gemin8 is a novel component of the survival motor neuron complex and functions in small nuclear ribonucleoprotein assembly. J Biol Chem 2006, 281(12):8126-8134. 10.1074/jbc.M512243200, 16434402.
12. Carissimi C, Baccon J, Straccia M, Chiarella P, Maiolica A, Sawyer A, Rappsilber J, Pellizzoni L. Unrip is a component of SMN complexes active in snRNP assembly. FEBS Lett 2005, 579(11):2348-2354. 10.1016/j.febslet.2005.03.034, 15848170.
13. Gabanella F, Butchbach ME, Saieva L, Carissimi C, Burghes AH, Pellizzoni L. Ribonucleoprotein assembly defects correlate with spinal muscular atrophy severity and preferentially affect a subset of spliceosomal snRNPs. PLoS ONE 2007, 2(9):e921. 10.1371/journal.pone.0000921, 1976558, 17895963.
14. Zhang Z, Lotti F, Dittmar K, Younis I, Wan L, Kasim M, Dreyfuss G. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 2008, 133(4):585-600. 10.1016/j.cell.2008.03.031, 2446403, 18485868.
15. Zhang HL, Pan F, Hong D, Shenoy SM, Singer RH, Bassell GJ. Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J Neurosci 2003, 23(16):6627-6637.
16. Rossoll W, Jablonka S, Andreassi C, Kroning AK, Karle K, Monani UR, Sendtner M. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J Cell Biol 2003, 163(4):801-812. 10.1083/jcb.200304128, 2173668, 14623865.
17. McWhorter ML, Monani UR, Burghes AH, Beattie CE. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J Cell Biol 2003, 162(5):919-931. 10.1083/jcb.200303168, 1761110,1761110, 12952942.
18. Winkler C, Eggert C, Gradl D, Meister G, Giegerich M, Wedlich D, Laggerbauer B, Fischer U. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev 2005, 19(19):2320-2330. 10.1101/gad.342005, 1240041, 16204184.
19. Cifuentes-Diaz C, Nicole S, Velasco ME, Borra-Cebrian C, Panozzo C, Frugier T, Millet G, Roblot N, Joshi V, Melki J. Neurofilament accumulation at the motor endplate and lack of axonal sprouting in a spinal muscular atrophy mouse model. Hum Mol Genet 2002, 11(12):1439-1447. 10.1093/hmg/11.12.1439, 12023986.
20. Murray LM, Comley LH, Thomson D, Parkinson N, Talbot K, Gillingwater TH. Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum Mol Genet 2008, 17(7):949-962. 10.1093/hmg/ddm367, 18065780.
21. Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT, Monani UR. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 2008, 17(16):2552-2569. 10.1093/hmg/ddn156, 2722888, 18492800.
22. McGovern VL, Gavrilina TO, Beattie CE, Burghes AH. Embryonic motor axon development in the severe SMA mouse. Hum Mol Genet 2008, 17:2900-2909. 10.1093/hmg/ddn189, 2722893, 18603534.
23. Kong L, Wang X, Choe DW, Polley M, Burnett BG, Bosch-Marce M, Griffin JW, Rich MM, Sumner CJ. Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J Neurosci 2009, 29(3):842-851. 10.1523/JNEUROSCI.4434-08.2009, 2746673, 19158308.
24. Le TT, Pham LT, Butchbach ME, Zhang HL, Monani UR, Coovert DD, Gavrilina TO, Xing L, Bassell GJ, Burghes AH. SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 2005, 14(6):845-857. 10.1093/hmg/ddi078, 15703193.
25. Monani UR, Sendtner M, Coovert DD, Parsons DW, Andreassi C, Le TT, Jablonka S, Schrank B, Rossol W, Prior TW, Morris GE, Burghes AH. The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet 2000, 9(3):333-339. 10.1093/hmg/9.3.333, 10655541.
26. Monani UR, Pastore MT, Gavrilina TO, Jablonka S, Le TT, Andreassi C, DiCocco JM, Lorson C, Androphy EJ, Sendtner M, Podell M, Burghes AH. A transgene carrying an A2G missense mutation in the SMN gene modulates phenotypic severity in mice with severe (type I) spinal muscular atrophy. J Cell Biol 2003, 160(1):41-52. 10.1083/jcb.200208079, 2172739, 12515823.
27. Park GH, Kariya S, Monani UR. Spinal muscular atrophy: new and emerging insights from model mice. Curr Neurol Neurosci Rep 2010, 10(2):108-117. 10.1007/s11910-010-0095-5, 2861773, 20425235.
28. Christou YA, Moore HD, Shaw PJ, Monk PN. Embryonic stem cells and prospects for their use in regenerative medicine approaches to motor neurone disease. Neuropathol Appl Neurobiol 2007, 33(5):485-498. 10.1111/j.1365-2990.2007.00883.x, 17854436.
29. Orlacchio A, Bernardi G, Martino S. Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases. Curr Med Chem 2010, 17(7):595-608. 10.2174/092986710790416272, 20088765.
30. Harper JM, Krishnan C, Darman JS, Deshpande DM, Peck S, Shats I, Backovic S, Rothstein JD, Kerr DA. Axonal growth of embryonic stem cell-derived motoneurons in vitro and in motoneuron-injured adult rats. Proc Natl Acad Sci USA 2004, 101(18):7123-7128. 10.1073/pnas.0401103101, 406476, 15118094.
31. Wichterle H, Lieberam I, Porter JA, Jessell TM. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110(3):385-397. 10.1016/S0092-8674(02)00835-8, 12176325.
32. Xu L, Yan J, Chen D, Welsh AM, Hazel T, Johe K, Hatfield G, Koliatsos VE. Human neural stem cell grafts ameliorate motor neuron disease in SOD-1 transgenic rats. Transplantation 2006, 82(7):865-875. 10.1097/01.tp.0000235532.00920.7a, 17038899.
33. Gao J, Coggeshall RE, Tarasenko YI, Wu P. Human neural stem cell-derived cholinergic neurons innervate muscle in motoneuron deficient adult rats. Neuroscience 2005, 131(2):257-262. 10.1016/j.neuroscience.2004.10.033, 15708470.
34. Deshpande DM, Kim YS, Martinez T, Carmen J, Dike S, Shats I, Rubin LL, Drummond J, Krishnan C, Hoke A, Maragakis N, Shefner J, Rothstein JD, Kerr DA. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006, 60(1):32-44. 10.1002/ana.20901, 16802299.
35. Sinha S, Chen JK. Purmorphamine activates the Hedgehog pathway by targeting Smoothened. Nat Chem Biol 2006, 2(1):29-30. 10.1038/nchembio753, 16408088.
36. Li XJ, Hu BY, Jones SA, Zhang YS, Lavaute T, Du ZW, Zhang SC. Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules. Stem Cells 2008, 26(4):886-893. 10.1634/stemcells.2007-0620, 2707816, 18238853.
37. Lamb TM, Harland RM. Fibroblast growth factor is a direct neural inducer, which combined with noggin generates anterior-posterior neural pattern. Development 1995, 121(11):3627-3636.
38. Storey KG, Goriely A, Sargent CM, Brown JM, Burns HD, Abud HM, Heath JK. Early posterior neural tissue is induced by FGF in the chick embryo. Development 1998, 125(3):473-484.
39. Launay C, Fromentoux V, Shi DL, Boucaut JC. A truncated FGF receptor blocks neural induction by endogenous Xenopus inducers. Development 1996, 122(3):869-880.
40. McMahon JA, Takada S, Zimmerman LB, Fan CM, Harland RM, McMahon AP. Noggin-mediated antagonism of BMP signaling is required for growth and patterning of the neural tube and somite. Genes Dev 1998, 12(10):1438-1452. 10.1101/gad.12.10.1438, 316831, 9585504.
41. Hsu SH, Lai MC, Er TK, Yang SN, Hung CH, Tsai HH, Lin YC, Chang JG, Lo YC, Jong YJ. Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts. Clin Chim Acta 2010, 411(23-24):1920-1928. 10.1016/j.cca.2010.07.035, 20713032.
42. Wishart TM, Huang JP, Murray LM, Lamont DJ, Mutsaers CA, Ross J, Geldsetzer P, Ansorge O, Talbot K, Parson SH, Gillingwater TH. SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 2010, 19(21):4216-4228. 10.1093/hmg/ddq340, 20705736.
43. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene 1999, 18(45):6087-6093. 10.1038/sj.onc.1203129, 10557099.
44. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev 2001, 81(2):807-869.
45. Anderson K, Potter A, Baban D, Davies KE. Protein expression changes in spinal muscular atrophy revealed with a novel antibody array technology. Brain 2003, 126(Pt 9):2052-2064. 10.1093/brain/awg208, 12847076.
46. Anderson P. TIA-1: structural and functional studies on a new class of cytolytic effector molecule. Curr Top Microbiol Immunol 1995, 198:131-143.
47. Hua Y, Zhou J. Survival motor neuron protein facilitates assembly of stress granules. FEBS Lett 2004, 572(1-3):69-74. 10.1016/j.febslet.2004.07.010, 15304326.
48. Tian Q, Taupin J, Elledge S, Robertson M, Anderson P. Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis. J Exp Med 1995, 182(3):865-874. 10.1084/jem.182.3.865, 2192163, 7544399.
49. Jung YS, Qian Y, Chen X. Examination of the expanding pathways for the regulation of p21 expression and activity. Cell Signal 2010, 22(7):1003-1012. 10.1016/j.cellsig.2010.01.013, 20100570.
50. Fuller HR, Man NT, Lam le T, Shamanin VA, Androphy EJ, Morris GE. Valproate and bone loss: iTRAQ proteomics show that valproate reduces collagens and osteonectin in SMA cells. J Proteome Res 2010, 9(8):4228-4233. 10.1021/pr1005263, 20568814.
51. Wen HL, Lin YT, Ting CH, Lin-Chao S, Li H, Hsieh-Li HM. Stathmin, a microtubule-destabilizing protein, is dysregulated in spinal muscular atrophy. Hum Mol Genet 2010, 19(9):1766-1778. 10.1093/hmg/ddq058, 20176735.
52. Veech RL. The metabolism of lactate. NMR Biomed 1991, 4(2):53-58. 10.1002/nbm.1940040204, 1859786.
53. Millino C, Fanin M, Vettori A, Laveder P, Mostacciuolo ML, Angelini C, Lanfranchi G. Different atrophy-hypertrophy transcription pathways in muscles affected by severe and mild spinal muscular atrophy. BMC Med 2009, 7:14. 10.1186/1741-7015-7-14, 2676312, 19351384.
54. Lin JJ, Eppinga RD, Warren KS, McCrae KR. Human tropomyosin isoforms in the regulation of cytoskeleton functions. Adv Exp Med Biol 2008, 644:201-222. full_text, 19209824.
55. Giesemann T, Rathke-Hartlieb S, Rothkegel M, Bartsch JW, Buchmeier S, Jockusch BM, Jockusch H. A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems. J Biol Chem 1999, 274(53):37908-37914. 10.1074/jbc.274.53.37908, 10608857.
56. Sharma A, Lambrechts A, Hao le T, Le TT, Sewry CA, Ampe C, Burghes AH, Morris GE. A role for complexes of survival of motor neurons (SMN) protein with gemins and profilin in neurite-like cytoplasmic extensions of cultured nerve cells. Exp Cell Res 2005, 309(1):185-197. 10.1016/j.yexcr.2005.05.014, 15975577.
57. Bowerman M, Shafey D, Kothary R. Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity. J Mol Neurosci 2007, 32(2):120-131. 10.1007/s12031-007-0024-5, 17873296.
58. Bowerman M, Anderson CL, Beauvais A, Boyl PP, Witke W, Kothary R. SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis. Mol Cell Neurosci 2009, 42(1):66-74. 10.1016/j.mcn.2009.05.009, 19497369.
59. Oprea GE, Krober S, McWhorter ML, Rossoll W, Muller S, Krawczak M, Bassell GJ, Beattie CE, Wirth B. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008, 320(5875):524-527. 10.1126/science.1155085, 18440926.
60. Chen JW, Dodia C, Feinstein SI, Jain MK, Fisher AB. 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem 2000, 275(37):28421-28427. 10.1074/jbc.M005073200, 10893423.
61. Acsadi G, Lee I, Li X, Khaidakov M, Pecinova A, Parker GC, Huttemann M. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy. J Neurosci Res 2009, 87(12):2748-2756. 10.1002/jnr.22106, 19437551.
62. Strey CW, Spellman D, Stieber A, Gonatas JO, Wang X, Lambris JD, Gonatas NK. Dysregulation of stathmin, a microtubule-destabilizing protein, and up-regulation of Hsp25, Hsp27, and the antioxidant peroxiredoxin 6 in a mouse model of familial amyotrophic lateral sclerosis. Am J Pathol 2004, 165(5):1701-1718. 10.1016/S0002-9440(10)63426-8, 1618651, 15509539.
63. Zou T, Ilangovan R, Yu F, Xu Z, Zhou J. SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity. Biochem Biophys Res Commun 2007, 364(4):850-855. 10.1016/j.bbrc.2007.10.096, 2169267, 17964281.
64. Morrison RS, Kinoshita Y. The role of p53 in neuronal cell death. Cell Death Differ 2000, 7(10):868-879. 10.1038/sj.cdd.4400741, 11279532.
65. Takeda K, Ichijo H. Neuronal p38 MAPK signalling: an emerging regulator of cell fate and function in the nervous system. Genes Cells 2002, 7(11):1099-1111. 10.1046/j.1365-2443.2002.00591.x, 12390245.
66. Dotto GP. p21(WAF1/Cip1): more than a break to the cell cycle?. Biochim Biophys Acta 2000, 1471(1):M43-56.
67. Gartel AL, Tyner AL. Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res 1999, 246(2):280-289. 10.1006/excr.1998.4319, 9925742.
68. Wang W, Dimatteo D, Funanage VL, Scavina M. Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death. Mol Genet Metab 2005, 85(1):38-45. 10.1016/j.ymgme.2004.12.015, 15862279.
69. Ilangovan R, Marshall WL, Hua Y, Zhou J. Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells. J Biol Chem 2003, 278(33):30993-30999. 10.1074/jbc.M303763200, 12783893.
70. Vyas S, Bechade C, Riveau B, Downward J, Triller A. Involvement of survival motor neuron (SMN) protein in cell death. Hum Mol Genet 2002, 11(22):2751-2764. 10.1093/hmg/11.22.2751, 12374765.
71. Trulzsch B, Garnett C, Davies K, Wood M. Knockdown of SMN by RNA interference induces apoptosis in differentiated P19 neural stem cells. Brain Res 2007, 1183:1-9. 10.1016/j.brainres.2007.09.025, 17976539.
72. Parker GC, Li X, Anguelov RA, Toth G, Cristescu A, Acsadi G. Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy. Neurotox Res 2008, 13(1):39-48. 10.1007/BF03033366, 18367439.
73. Tsai MS, Chiu YT, Wang SH, Hsieh-Li HM, Lian WC, Li H. Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice. Mol Ther 2006, 13(6):1149-1155. 10.1016/j.ymthe.2006.02.008, 16564230.
74. Tsai LK, Tsai MS, Ting CH, Wang SH, Li H. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy. Neurobiol Dis 2008,
75. Wu CY, Gomez-Curet I, Funanage VL, Scavina M, Wang W. Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin is p53-independent. BMC Cell Biol 2009, 10:40. 10.1186/1471-2121-10-40, 2692972, 19445707.